Comparison between Le Travenues Technology IPO and Kronox Lab Sciences IPO.
Le Travenues Technology IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Kronox Lab Sciences IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Le Travenues Technology IPO is up to ₹740.10 Cr whereas the issue size of the Kronox Lab Sciences IPO is up to ₹130.15 Cr. The final issue price of Le Travenues Technology IPO is ₹93.00 per share and of Kronox Lab Sciences IPO is ₹136.00 per share.
| Le Travenues Technology IPO | Kronox Lab Sciences IPO | |
|---|---|---|
| Face Value | ₹1 per share | ₹10 per share |
| Issue Price (Lower) | ₹88.00 per share | ₹129.00 per share |
| Issue Price (Upper) | ₹93.00 per share | ₹136.00 per share |
| Issue Price (Final) | ₹93.00 per share | ₹136.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 161 shares | 110 shares |
| Fresh Issue Size | 1,29,03,225 shares | 0 shares |
| Fresh Issue Size (Amount) | up to ₹120.00 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 6,66,77,674 shares | 95,70,000 shares |
| OFS Issue Size (Amount) | up to ₹620.10 Cr | up to ₹130.15 Cr |
| Issue Size Total | 7,95,80,899 shares | 95,70,000 shares |
| Issue Size Total (Amount) | up to ₹740.10 Cr | up to ₹130.15 Cr |
Le Travenues Technology IPO opens on Jun 10, 2024, while Kronox Lab Sciences IPO opens on Jun 03, 2024. The closing date of Le Travenues Technology IPO and Kronox Lab Sciences IPO is Jun 12, 2024, and Jun 05, 2024, respectively.
| Le Travenues Technology IPO | Kronox Lab Sciences IPO | |
|---|---|---|
| Anchor Bid Date | Jun 07, 2024 | May 31, 2024 |
| Issue Open | Jun 10, 2024 | Jun 03, 2024 |
| Issue Close | Jun 12, 2024 | Jun 05, 2024 |
| Basis Of Allotment (Tentative) | Jun 13, 2024 | Jun 06, 2024 |
| Initiation of Refunds (Tentative) | Jun 14, 2024 | Jun 07, 2024 |
| Credit of Share (Tentative) | Jun 14, 2024 | Jun 07, 2024 |
| Listing date (Tentative) | Jun 18, 2024 | Jun 10, 2024 |
| Anchor Lockin End date 1 | Jul 13, 2024 | Jul 06, 2024 |
| Anchor Lockin End date 2 | Sep 11, 2024 | Sep 04, 2024 |
Le Travenues Technology IPO P/E ratio is 148.87, as compared to Kronox Lab Sciences IPO P/E ratio of 30.37.
| Le Travenues Technology IPO | Kronox Lab Sciences IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 99.98 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 74.21 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 148.87 | 30.37 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹3603.04 Cr. | ₹504.61 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 25.66% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 33.15% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹0.62 | ₹4.48 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 15.26% | 25.66% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Le Travenues Technology IPO Retail Individual Investors (RII) are offered 79,58,089 shares while in Kronox Lab Sciences IPO retail investors are offered 79,58,089 shares. Qualified Institutional Buyers (QIB) are offered 2,38,74,271 shares in Le Travenues Technology IPO and 19,14,000 shares in Kronox Lab Sciences IPO.
| Le Travenues Technology IPO | Kronox Lab Sciences IPO | |
|---|---|---|
| Anchor Investor Reservation | 3,58,11,405 shares | 28,71,000 shares |
| Market Maker Reservation | ||
| QIB | 2,38,74,271 shares | 19,14,000 shares |
| NII | 1,19,37,134 shares | 14,35,500 shares |
| RII | 79,58,089 shares | 33,49,500 shares |
| Employee | ||
| Others | ||
| Total | 7,95,80,899 shares | 95,70,000 shares |
Le Travenues Technology IPO subscribed 98.10x in total, whereas Kronox Lab Sciences IPO subscribed 117.25x.
| Le Travenues Technology IPO | Kronox Lab Sciences IPO | |
|---|---|---|
| QIB (times) | 106.73x | 89.03x |
| NII (times) | 110.25x | 301.92x |
| Big NII (times) | 117.40x | 322.26x |
| Small NII (times) | 95.95x | 261.22x |
| RII (times) | 53.95x | 54.24x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 98.10x | 117.25x |
